Psychedelic Drug Fights Chemo Nerve Damage

Early research indicates that the psychedelic compound psilocybin shows promise in preventing nerve damage associated with chemotherapy. Studies conducted on mice demonstrated that psilocybin protected sensory nerve endings and preserved touch sensation. It also shielded nerve cells' mitochondria, crucial energy-producing components, from chemotherapy's detrimental effects. These findings suggest a potential therapeutic avenue for managing chemotherapy side effects.

In parallel, a different study has revealed previously unrecognized impacts of the Clostridioides difficile (C. diff) bacterium on infants. While C. diff causes severe gastrointestinal issues in adults, it appears to affect babies differently. Without producing overt symptoms, the bacteria have been observed to remodel the developing infant gut and alter immune system development, potentially leading to long-term consequences into adulthood.